Features of the oxidant and antioxidant balance in patients with obesity, steatohepatitis and chronic kidney disease

Read full text Summarise with VIRAT
Authors: А. А. Антонів, Людмила Володимирівна Каньовська, N.A. Antoniv, L.V. Mikulets, Yu.M. Yarinich, О. О. Maksymiv
Cited by: 0
References: 22

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background. Metabolic dysfunction-associated steatotic liver disease and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are increasingly regarded as systemic conditions. The purpose was to evaluate the intensity of oxidative stress and the functional state of the antioxidant defense system in patients with metabolic dysfunction-associated steatohepatitis and class I–II obesity, depending on the presence, clinical variant, and stage of chronic kidney disease (CKD), and to determine their pathogenetic role in the mechanisms of liver-kidney mutual aggravation. Materials and methods. This study included 177 adult patients with MASH and class I–II obesity who were stratified according to renal status: no kidney involvement, CKD stages I–III, gouty nephropathy, or asymptomatic hyperuricemia. A control group consisted of 30 apparently healthy individuals matched for age and sex. Lipid peroxidation intensity, oxidative protein modification, and antioxidant defense parameters were assessed using standardized biochemical and spectrophotometric methods. Renal function was evaluated by estimated glomerular filtration rate. Statistical analysis included intergroup comparisons and correlation analysis. Results. All clinical groups demonstrated a significant activation of lipid peroxidation and impairment of antioxidant defense, indicating the development of decompensated oxidative stress (p < 0.05). The highest oxidative stress was observed in patients with MASH and comorbid CKD and increased progressively with declining glomerular filtration rate. In contrast, patients with asymptomatic hyperuricemia exhibited a lower oxidative stress burden, whereas oxidative damage markers increased again in the presence of gouty nephropathy. Reduced glutathione depletion and suppression of superoxide dismutase activity reflected exhaustion of antioxidant reserves. Significant correlations were identified between lipid peroxidation markers, liver enzyme activity, and renal function parameters, supporting a close pathogenetic link between hepatic and renal dysfunction. Conclusions. Oxidative stress is a key pathogenetic mechanism in MASH and plays a central role in liver-kidney interaction, particularly in the presence and progression of CKD. The stage- and phenotype-dependent alterations of oxidant-antioxidant balance highlight oxidative stress as a potential target for risk stratification and pathogenetically oriented therapeutic strategies in patients with MASH and comorbid renal pathology.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Antioxidant Activity and Oxidative Stress Chronic Kidney Disease and Diabetes

Publication details

Journal / source
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
Volume
22
Issue
2
Pages
119–125
Publication date
27 March 2026
Language
EN